ATP and sulfonylurea linkage in the KATP channel solves a diabetes puzzler

Diabetes

Volumn 62, Issue 11, 2013, Pages 3666-3668

  Drain, Peter ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; C PEPTIDE; INSULIN; SULFONYLUREA; SULFONYLUREA RECEPTOR 1; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; GLICLAZIDE; INWARDLY RECTIFYING POTASSIUM CHANNEL; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2;

BINDING SITE; DIABETES MELLITUS; DRUG BINDING; GENE MUTATION; GENETIC PREDISPOSITION; GLYCEMIC CONTROL; HUMAN; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NOTE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; ANIMAL; DRUG EFFECTS; GENETICS; INSULIN DEPENDENT DIABETES MELLITUS; DRUG EFFECT;

ANIMALS; DIABETES MELLITUS, TYPE 1; GLICLAZIDE; HUMANS; KATP CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING;

EID: 84891719479     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-1194     Document Type: Note

References (21)

1. Wyman J Jr. Linked functions and reciprocal effects in hemoglobin: a second look. Adv Protein Chem 1964;19:223-286
2. Proks P, de Wet H, Ashcroft FM. Molecular mechanism of sulphonylurea block of KATP channels carrying mutations that impair ATP inhibition and cause neonatal diabetes. Diabetes 2013;62:3909-3919
3. Proks P, Ashcroft FM. Modeling K(ATP) channel gating and its regulation. Prog Biophys Mol Biol 2009;99:7-19
4. Drain P, Geng X, Li L. Concerted gating mechanism underlying KATP channel inhibition by ATP. Biophys J 2004;86:2101-2111
5. Markworth E, Schwanstecher C, Schwanstecher M. ATP4- mediates closure of pancreatic β-cell ATP-sensitive potassium channels by interaction with 1 of 4 identical sites. Diabetes 2000;49:1413-1418
6. Dörschner H, Brekardin E, Uhde I, Schwanstecher C, Schwanstecher M. Stoichiometry of sulfonylurea-induced ATP-sensitive potassium channel closure. Mol Pharmacol 1999;55:1060-1066
7. Gribble FM, Tucker SJ, Ashcroft FM. The interaction of nucleotides with the tolbutamide block of cloned ATP-sensitive K+ channel currents expressed in Xenopus oocytes: a reinterpretation. J Physiol 1997;504: 35-45
8. Proks P, Reimann F, Green N, Gribble F, Ashcroft F. Sulfonylurea stimulation of insulin secretion. Diabetes 2002;51(Suppl. 3):S368-S376
9. Gribble FM, Reimann F. Sulphonylurea action revisited: the post-cloning era. Diabetologia 2003;46:875-891
10. Kakei M, Kelly RP, Ashcroft SJ, Ashcroft FM. The ATP-sensitivity of K+ channels in rat pancreatic β-cells is modulated by ADP. FEBS Lett 1986; 208:63-66
11. Misler S, Falke LC, Gillis K, McDaniel ML. A metabolite-regulated potassium channel in rat pancreatic B cells. Proc Natl Acad Sci USA 1986;83: 7119-7123
12. Zingman LV, Alekseev AE, Bienengraeber M, et al. Signaling in channel/enzyme multimers: ATPase transitions in SUR module gate ATP-sensitive K+ conductance. Neuron 2001;31:233-245
13. Sagen JV, Raeder H, Hathout E, et al. Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy. Diabetes 2004;53:2713- 2718
14. Pearson ER, Flechtner I, Njølstad PR, et al.; Neonatal Diabetes International Collaborative Group. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 2006; 355:467-477.
15. Masia R, Koster JC, Tumini S, et al. An ATP-binding mutation (G334D) in KCNJ11 is associated with a sulfonylurea-insensitive form of developmental delay, epilepsy, and neonatal diabetes. Diabetes 2007;56:328-336
16. Drain P, Li LH, Wang J. KATP channel inhibition by ATP requires distinct functional domains of the cytoplasmic C terminus of the pore-forming subunit. Proc Natl Acad Sci USA 1998;95:13953-13958
17. Li L, Geng X, Yonkunas M, et al. Ligand-dependent linkage of the ATP site to inhibition gate closure in the KATP channel. J Gen Physiol 2005;126: 285-299
18. Antcliff JF, Haider S, Proks P, Sansom MS, Ashcroft FM. Functional analysis of a structural model of the ATP-binding site of the KATP channel Kir6.2 subunit. EMBO J 2005;24:229-239
19. Remedi MS, Kurata HT, Scott A, et al. Secondary consequences of beta cell inexcitability: identification and prevention in a murine model of K(ATP)- induced neonatal diabetes mellitus. Cell Metab 2009;9:140-151
20. Rafiq M, Flanagan SE, Patch AM, Shields BM, Ellard S, Hattersley AT, Neonatal Diabetes International Collaborative Group. Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations. Diabetes Care 2008;31:204-209
21. Hammes GG, Wu CW. Kinetics of allosteric enzymes. Annu Rev Biophys Bioeng 1974;3:1-33